A 52-year-old man with newly diagnosed acute myeloid leukaemia (AML) is being initiated on induction chemotherapy. The oncologist selects a nucleoside analogue that inhibits ribonucleotide reductase and is incorporated into DNA, causing chain termination. Which drug is the drug of choice for induction therapy in AML?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.